TREM2 and Alzheimer disease: Despite evidence supporting the impact of full-length TREM2, sTREM2, and their variants on AD pathogenesis, coupled with growing interest in therapies targeting TREM2, further mechanistic studies are required to elucidate the stage-specific contributions of TREM2 in AD.